PROMOMED experts presented modern approaches to correcting metabolic health within the framework of INNOPROM-2026

Kira Zaslavskaya, Director of New Products at PROMOMED, spoke at the meeting of the section "Professional longevity: workplace for health and well-being. Nutrition balance for a healthy weight in a 24/7 schedule" of the first Forum of Women Entrepreneurs, which was held as part of the International Industrial Exhibition INNOPROM-2026. The meeting was moderated by Inna Svyatenko, Deputy Chairman of the Federation Council.

At the event, leading medical experts, scientists, and government officials discussed how metabolic health affects performance and quality. Kira Zaslavskaya presented an overview of key changes in approaches to correcting metabolic disorders over the past 15 years. According to her, the main transformation is related to a paradigm shift: from a focus on combating obesity to a comprehensive strategy for caring for metabolic health.

Special attention in the presentation was paid to modern pharmacological approaches. The PROMMED expert noted that significant progress in therapy is associated with the targeting of peripheral hormonal systems of the gastrointestinal tract and the creation of drugs that mimic the action of the body's natural regulators. Such solutions include liraglutide and semaglutide, which help regulate eating behavior, reduce insulin resistance, and control lipid metabolism. The next step in the development of this area was the creation of drugs that act on several receptors simultaneously. This mechanism allows for a broader influence on the metabolic cascade, including adipose tissue. The most important task is to reduce fat, not muscle mass, with a focus on visceral fat: it is associated with increased risks of metabolic and cardiovascular complications.

Science and manufacturers continue to work on molecules with multiple targets and develop nature-like technologies focused on physiology and safety. As a developer, PROMOMED focuses on forms without preservatives. They are preferred for long-term therapy and in patients with concomitant liver or kidney diseases. The success of treatment today is assessed not only in the kilograms lost, but also in clinical effects such as cardio and nephroprotection, reduction of the risk of complications and progression of metabolic diseases.

A separate topic was the understanding of obesity as a model of accelerated biological aging. As noted by Kira Zaslavskaya, these processes have common molecular and cellular markers, and the strategy of prevention and therapy is increasingly being considered in the logic of maintaining a period of active longevity.

During her speech, the PROMOMED expert spoke about preventive initiatives implemented with the participation of the medical community and regional partners. Yekaterinburg has launched a joint project of the Ural State Medical University and Academician of the Russian Academy of Sciences Olga Petrovna Kovtun "Family Alliance", aimed at the formation of healthy eating habits in the family. In Mordovia, there is a "Start with yourself" program. Initially, its goal was to reduce the metabolic risks of the employees of the Biochemist plant. Later, the initiative was expanded to the medical community, and then to other regions. With the participation of the Federation Council, the program opened in Nizhny Novgorod. Samara and a number of other cities are planned.

"We consistently instill a culture of caring for metabolic health, because it helps prevent premature aging and increases life expectancy," concluded Kira Zaslavskaya.